Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
X-linked hypophosphatemia (XLH) is the most common form of heritable rickets. Current
treatments include active vitamin D metabolites (e.g. calcitriol) and phosphate salts. There
is no consistent weight-based dosing of calcitriol and phosphate now. The primary objective
of this study is to establish the efficacy of different dose of calcitriol combined with
neutral phosphate in children with XLH.